Bioconjugation CMC – Successfully Executing a Complex Process | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Bioconjugation CMC – Successfully Executing a Complex Process

Scott Miller, PhD (Senior Scientific Advisor, CARBOGEN AMICS AG)

Location: bioLIVE Theater

Date: Tuesday, April 30

Time: 1:40pm - 2:00pm

Track: The BPI Theater

Vault Recording: TBD

A look at the individual components of a typical Antibody Drug Conjugate and the challenges posed scaling their manufacture for pre-clinical and clinical studies
• Process knowledge transfer to your chosen CMO. Common pitfalls and how to avoid them.
• Managing all the moving pieces to bring your ADC to the clinic. What does developing an ADC have in common with a small molecule process and what is unique?
• Models will be included to illustrate the topics being presented.